Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure
SGLT2i affect body composition, reduce cardiac load, improve diastolic/systolic function, and attenuate the sympathetic response. Glycemic control contributes to the improvement of heart function, blood pressure control, oxidative stress, and reduction in inflammation.
Authors
- Maja Cigrovski Berković (ORCID: https://orcid.org/0000-0003-0750-9785)
- Luka Rotkvić
- Petra Grubić Rotkvić (ORCID: https://orcid.org/0000-0002-2587-1932)
- Ana Đuzel Čokljat
Institutions
- University Hospital Centre Zagreb (HR)
- Magna International (Germany) (DE)
- University of Dubrovnik (HR)
- University of Zagreb (HR)
Publication Details
- Journal
- World Journal of Cardiology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.4330/wjc.v16.i8.448
- Citations
- 6
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.15